Penehyclidine hydrochloride(Xianyang Pharma)

盐酸戊乙奎醚吸入溶液（先洋医药）

Report date: 2025/03/24 17:51:08

Base Information

Drug NamePenehyclidine hydrochloride(Xianyang Pharma)
Drug Alias Name盐酸戊乙奎醚吸入溶液（2.2类改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChongqing Xianyang Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Xianyang Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A